UM  > Faculty of Health Sciences  > DEPARTMENT OF PHARMACEUTICAL SCIENCES
Browse Items

Browse/Search Results:  1-10 of 1162 Help

Filters                
Selected(0)Clear Items/Page:    Sort:
Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors Journal article
International Immunopharmacology, 2024,Volume: 132,Page: 111947
Authors:  Zou, Huimin;  Ge, Ying;  Chen, Wenge;  Yao, Dongning;  Oi Lam Ung, Carolina; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.600/5.600 | Submit date:2024/05/16
Camrelizumab  China  Hepatocellular Carcinoma  Programmed Cell Death Protein-1 Inhibitor  Tislelizumab  
Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration Journal article
Journal of Hepatology, 2024,Volume: 80,Issue: 5,Page: 753-763
Authors:  Wang Zhenzhen;  Xie Daping;  Li Jiayi;  Zhai Ziyu;  Lu Zhoujian; et al.
Favorite | TC[Scopus]:0  IF:25.700/26.200 | Submit date:2024/01/25
Artemisinin Confers Cytoprotection toward Hydrogen Peroxide-Induced Cell Apoptosis in Retinal Pigment Epithelial Cells in Correlation with the Increased Acetylation of Histone H4 at Lysine 8 Journal article
Molecules, 2024,Volume: 29,Issue: 8
Authors:  Yang, Chao;  Ge, Lijun;  Yu, Xiyong;  Lazarovici, Philip;  Zheng, Wenhua
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.600/4.900 | Submit date:2024/05/16
Acetyl-h4 (Lys 8)  Apoptosis  Artemisinin  Cytoprotection  H2o2  Retinal Pigment Epithelial Cells  
Therapeutic role of PTEN in tissue regeneration for management of neurological disorders: stem cell behaviors to an in-depth review Review article
2024
Authors:  Li, Yue;  Ma, Ruishuang;  Hao, Xia
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:9.000/9.200 | Submit date:2024/05/02
Corticospinal Tract Axons  Progenitor Cells  Differentiation  Promotes  Growth  Beta  Deletion  Neurogenesis  Maintenance  Activation  
Medicinal plants and natural products for treating overactive bladder Review article
2024
Authors:  Chen, Huanxian;  Hoi, Maggie Pui Man;  Lee, Simon Ming Yuen
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.900/6.000 | Submit date:2024/05/16
Medicinal Plants  Natural Products  Overactive Bladder  
J24335 exerts neuroprotective effects against 6-hydroxydopamine-induced lesions in PC12 cells and mice Journal article
European Journal of Pharmaceutical Sciences, 2024,Volume: 194,Page: 1-18
Authors:  Pan, Zhijian;  Shao, Min;  Zhao, Chen;  Yang, Xuanjun;  Li, Haitao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.600/4.300 | Submit date:2024/04/02
6-ohda  J24335  Mitochondria Dysfunction  Neurotoxicity  Parkinson's Disease  Target Prediction  
Paraptosis: a non-classical paradigm of cell death for cancer therapy Review article
2024
Authors:  Xu, Chun cao;  Lin, Yi fan;  Huang, Mu yang;  Zhang, Xiao lei;  Wang, Pei; et al.
Favorite | TC[WOS]:8 TC[Scopus]:7  IF:8.200/8.200 | Submit date:2024/02/22
Cancer Therapy  Endoplasmic Reticulum  Er Stress  Mitochondria  Paraptosis  
Antagonizing pathological α-synuclein-mediated neurodegeneration by J24335 via the activation of immunoproteasome Journal article
Toxicology and Applied Pharmacology, 2023,Volume: 480,Page: 116745
Authors:  Pan, Zhijian;  Yu, Chao Wu;  Zhao, Chen;  Shao, Min;  Yang, Xuanjun; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.800/4.000 | Submit date:2024/01/02
Immunoproteasome  J24335  Lmp7  Parkinson's Disease  Protein Degradation  Α-synuclein  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:1 TC[Scopus]:1  IF:6.200/6.800 | Submit date:2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 Journal article
Pharmacological Research, 2023,Volume: 198,Page: 106988
Authors:  Huang, Mu Yang;  Chen, Yu Chi;  Lyu, Wen Yu;  He, Xin Yu;  Ye, Zi Han; et al.
Favorite | TC[WOS]:1 TC[Scopus]:3  IF:9.300/8.800 | Submit date:2024/01/02
Combination Treatment  Ginsenoside Rh2  Pd-1/pd-l1  t Cells  Tumor Microenvironment